- AU$1.19bn
- AU$1.14bn
- $0.55m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 14.85 | ||
Price to Tang. Book | 14.85 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1,396.63 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -41.31% | ||
Return on Equity | -60.76% | ||
Operating Margin | -3963.18% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 0.02 | 0.01 | 0.4 | 0.49 | 0.55 | 4.64 | 16.97 | 76.91% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
IperionX Limited is a titanium metal and critical materials company that uses patented metal technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, at lower energy and carbon emissions. It is engaged in the exploration and evaluation of its mineral properties in the United States and the research, development, and commercialization of its associated metals technologies to support an integrated titanium processing operation. It holds a 100% interest in the Titan Project, covering more than 11,000 acres of mineral properties in western Tennessee, which it considers prospective for critical minerals including titanium, rare earth elements, silica sand and zircon. Its titanium metal and critical minerals are essential for advanced United States industries including space, aerospace, defense, consumer electronics, hydrogen, electric vehicles and additive manufacturing. It has commissioned hydrogen assisted metallothermic reduction furnace.
Directors
- Todd Hannigan CHM (48)
- Anastasios Arima CEO
- Gregory Swan SEC (40)
- Vaughn Taylor NED
- Lorraine Martin NID (59)
- Melissa Waller NID
- Beverly Wyse NID
- Last Annual
- June 30th, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- May 5th, 2017
- Public Since
- April 16th, 2018
- No. of Shareholders
- 2,307
- Sector
- Metals & Mining
- Industry
- Basic Materials
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 257,244,759
- Address
- 129 W Trade St, Suite 1405, CHARLOTTE, 28202
- Web
- https://iperionx.com/
- Phone
- +1 9802378900
- Auditors
- PricewaterhouseCoopers
Upcoming Events for IPX
Half Year 2025 Iperionx Ltd Earnings Release
Similar to IPX
29Metals
Australian Stock Exchange - SEATS
5E Advanced Materials
Australian Stock Exchange - SEATS
Abarta Resources
Australian Stock Exchange - SEATS
ABx
Australian Stock Exchange - SEATS
Accelerate Resources
Australian Stock Exchange - SEATS
FAQ
As of Today at 20:23 UTC, shares in Iperionx are trading at AU$4.64. This share price information is delayed by 15 minutes.
Shares in Iperionx last closed at AU$4.64 and the price had moved by +248.87% over the past 365 days. In terms of relative price strength the Iperionx share price has outperformed the ASX All Ordinaries Index by +197.6% over the past year.
The overall consensus recommendation for Iperionx is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreIperionx does not currently pay a dividend.
Iperionx does not currently pay a dividend.
Iperionx does not currently pay a dividend.
To buy shares in Iperionx you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$4.64, shares in Iperionx had a market capitalisation of AU$1.19bn.
Here are the trading details for Iperionx:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: IPX
Based on an overall assessment of its quality, value and momentum Iperionx is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Iperionx is AU$4.95. That is 6.68% above the last closing price of AU$4.64.
Analysts covering Iperionx currently have a consensus Earnings Per Share (EPS) forecast of -$0.02 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Iperionx. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +114.27%.
As of the last closing price of AU$4.64, shares in Iperionx were trading +76.58% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Iperionx PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$4.64.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Iperionx's management team is headed by:
- Todd Hannigan - CHM
- Anastasios Arima - CEO
- Gregory Swan - SEC
- Vaughn Taylor - NED
- Lorraine Martin - NID
- Melissa Waller - NID
- Beverly Wyse - NID